NCT06720701View on ClinicalTrials.gov

Development of Prognostic Models for Response and Toxicity to CAR-T Cell Therapy in Patients with Relapsed/refractory Non Hodgkin's Lymphoma.

Not yet recruitingOBSERVATIONAL

Enrollment

125

Participants

Timeline

Start Date

December 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

Non-Hodgkin Lymphoma

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER